Bilian Yu

发表

Association between Cardiovascular Burden and Requirement of Intensive Care among Patients with Mild COVID-19

X. Chai, Liang Tang, Mingxian Chen, 2020, Cardiovascular therapeutics.

Synthetic high-density lipoproteins delivering liver X receptor agonist prevent atherogenesis by enhancing reverse cholesterol transport.

Y. E. Chen, Jifeng Zhang, J. Moon, 2020, Journal of controlled release : official journal of the Controlled Release Society.

Synthetic High-Density Lipoprotein-Mediated Targeted Delivery of Liver X Receptors Agonist Promotes Atherosclerosis Regression

Jifeng Zhang, J. Moon, A. Schwendeman, 2017, EBioMedicine.

Interaction between adipocytes and high-density lipoprotein:new insights into the mechanism of obesity-induced dyslipidemia and atherosclerosis

Danyan Xu, Bilian Yu, Tianhua Zhang, 2019, Lipids in Health and Disease.

HDL-associated apoCIII plays an independent role in predicting postprandial hypertriglyceridemia.

Danyan Xu, Bilian Yu, Daoquan Peng, 2020, Clinical biochemistry.

Evaluation of variation in D-dimer levels among COVID-19 and bacterial pneumonia: a retrospective analysis

L. Tang, Bilian Yu, Xianling Liu, 2020, Journal of Thrombosis and Thrombolysis.

Comparison of calculated remnant lipoprotein cholesterol levels with levels directly measured by nuclear magnetic resonance

Bilian Yu, Daoquan Peng, Jin Chen, 2020, Lipids in Health and Disease.

High-Sensitivity CRP is Independently Associated with HDL-Mediated Cholesterol Efflux Capacity and HDL Remodeling in Patients with Coronary Artery Disease

Bilian Yu, Daoquan Peng, Tianhua Zhang, 2020 .

ANGPTL3 Is Involved in the Post-prandial Response in Triglyceride-Rich Lipoproteins and HDL Components in Patients With Coronary Artery Disease

Zhijie Huang, Bilian Yu, Daoquan Peng, 2022, Frontiers in Cardiovascular Medicine.

HDL quality features revealed by proteome‒lipidome connectivity are associated with atherosclerotic disease

Y. E. Chen, Jifeng Zhang, Jia-Rui Wu, 2020, Journal of molecular cell biology.

Clinical Profile and Prognosis of Hereditary Transthyretin Amyloid Cardiomyopathy: A Single-Center Study in South China

Yang Yang, Bilian Yu, Daoquan Peng, 2022, Frontiers in Cardiovascular Medicine.

Mechanisms of unusual response to lipid-lowering therapy: PCSK9 inhibition.

Bilian Yu, Daoquan Peng, M. Ouyang, 2022, Clinica chimica acta; international journal of clinical chemistry.

Inflamed adipose tissue: A culprit underlying obesity and heart failure with preserved ejection fraction

Chenyu Li, Bilian Yu, Jiarui Hu, 2022, Frontiers in Immunology.

Prevalence of dyslipidaemia in patients treated with lipid-lowering agents in China: results of the DYSlipidemia International Study (DYSIS).

Xiaowei Yan, Yongjun Wang, Y. Mu, 2014, Atherosclerosis.

Intraventricular muscle bundle as a novel cause of left ventricular aneurysm

Bilian Yu, Daoquan Peng, Junyu Pei, 2020, BMC Cardiovascular Disorders.

Aberrant Mitochondrial Dynamics: An Emerging Pathogenic Driver of Abdominal Aortic Aneurysm

Bilian Yu, Mi Wang, M. Ouyang, 2021, Cardiovascular therapeutics.

Retrospective analysis of clinical phenotype and prognosis of hypertrophic cardiomyopathy complicated with hypertension

Bilian Yu, Tianhua Zhang, Jin Chen, 2020, Scientific Reports.

High-density Lipoprotein Increases the Uptake of Oxidized Low Density Lipoprotein via PPARγ/CD36 Pathway in Inflammatory Adipocytes

Zhisheng Jiang, Yunping Li, R. Matyal, 2015, International journal of biological sciences.

High-sensitivity CRP may be a marker of HDL dysfunction and remodeling in patients with acute coronary syndrome

Bilian Yu, Daoquan Peng, Tianhua Zhang, 2021, Scientific Reports.

Nuclear magnetic resonance reveals postprandial low-density lipoprotein cholesterol determined by enzymatic method could be a misleading indicator.

Bilian Yu, Daoquan Peng, Shuguang Yuan, 2020, Clinica chimica acta; international journal of clinical chemistry.

New Insight Into Metformin-Induced Cholesterol-Lowering Effect Crosstalk Between Glucose and Cholesterol Homeostasis via ChREBP (Carbohydrate-Responsive Element-Binding Protein)-Mediated PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Regulation.

Y. E. Chen, Jifeng Zhang, R. Wu, 2021, Arteriosclerosis, thrombosis, and vascular biology.

Loss of APOO (MIC26) aggravates obesity-related whitening of brown adipose tissue via PPARα-mediated functional interplay between mitochondria and peroxisomes.

Yang Yang, Bilian Yu, Feng Wang, 2023, Metabolism: clinical and experimental.

Pericardial Sarcoma: "Invisible" on Radiology.

Shenghua Zhou, Bilian Yu, Boxuan Hu, 2019, The Canadian journal of cardiology.

Comparison of calculated remnant lipoprotein cholesterol levels with levels directly measured by nuclear magnetic resonance

Bilian Yu, Daoquan Peng, Jin Chen, 2020, Lipids in Health and Disease.

Association between Cardiovascular Burden and Requirement of Intensive Care among Patients with Mild COVID-19

X. Chai, Liang Tang, Mingxian Chen, 2020, medRxiv.

Retrospective analysis of clinical phenotype and prognosis of hypertrophic cardiomyopathy complicated with hypertension

Bilian Yu, Tianhua Zhang, Jin Chen, 2020, Scientific Reports.

L51P, a novel mutation in the PAS domain of hERG channel, confers long QT syndrome by impairing channel activation.

Bilian Yu, Daoquan Peng, Min Gao, 2020, American journal of translational research.

Macrophage-specific deletion of MIC26 (APOO) mitigates advanced atherosclerosis by increasing efferocytosis.

Bilian Yu, Jin Chen, Xiaoyu Tang, 2023, Atherosclerosis.